ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2020
Tc-99m-PYP imaging for cardiac amyloidosis: Defining the best protocol before the flood gates burst.
Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- QuantitativeEuropean journal of nuclear medicine and molecular imaging · 2026Article
- Visceral technetium-99 m-labeled pyrophosphate uptake in patients with wild-type transthyretin cardiac amyloidosis.Annals of nuclear medicine · 2026Article
- From Molecular to Radionuclide and Pharmacological Aspects in Transthyretin Cardiac Amyloidosis.International journal of molecular sciences · 2024Review
- Time is a gift: time-dependent uptake of DPD in cardiac amyloidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis.Japanese journal of radiology · 2023Article
- Assessment of Interobserver Agreement in the Interpretation ofAnnals of nuclear cardiology · 2023Article
- Enhanced quantitative method for the diagnosis of grade 1 cardiac amyloidosis inScientific reports · 2022Article
- Pitfalls of the Semi-Quantitative AnalyzingDiagnostics (Basel, Switzerland) · 2022Article
- A cardiology fellow's take-home points from ASNC's Webinar: Cases in Tc 99m-PYP evaluation of ATTR cardiac amyloidosis - interpretation and reporting.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021Article
- The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update.Frontiers in cardiovascular medicine · 2020Review
Corrections and comments
- Comment on
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32676915What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.